Skip to main content
. 2023 Jan 26;14:1088187. doi: 10.3389/fmicb.2023.1088187

Figure 6.

Figure 6

(A) Correlation analysis of islet β cell indices and intestinal bacterial community after metformin treatment. (B) Correlation analysis of islet β cell indices and intestinal bacterial community after liraglutide treatment. (C) Correlation analysis of inflammation-related factors and intestinal bacterial community after metformin treatment. (D) Correlation analysis of inflammation-related factors and intestinal bacterial community after liraglutide treatment. (E) Correlation analysis of lipid metabolism indices and intestinal bacterial community after metformin treatment. (F) Correlation analysis of lipid metabolism indices and intestinal bacterial community after liraglutide treatment. (G) Correlation analysis of liver function indices and intestinal bacterial community after metformin treatment. (H) Correlation analysis of liver function indices and intestinal bacterial community after liraglutide treatment.